The paper describes the opportunity of treating patients affected by TRAPS with tumor necrosis factor inhibitors
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), formerly known as familial Hibe...
Management of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is puzzling, and t...
Objective. Tumor necrosis factor receptor (TNFR) -associated periodic syndrome (TRAPS) is an autosom...
Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) is an autosomal dominant a...
Tumor necrosis factor-alpha receptor (TNFR1)-associated periodic syndrome (TRAPS) is the most common...
Tumor necrosis factor-alpha receptor (TNFR1)-associated periodic syndrome (TRAPS) is the most common...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
The anti-IL1 drug canakinumab has been administered in a patient with a high-penetrance T50M TNFRSF1...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is an autosomal dominantly inher...
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), formerly known as familial Hibe...
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), formerly known as familial Hibe...
Management of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is puzzling, and t...
Objective. Tumor necrosis factor receptor (TNFR) -associated periodic syndrome (TRAPS) is an autosom...
Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) is an autosomal dominant a...
Tumor necrosis factor-alpha receptor (TNFR1)-associated periodic syndrome (TRAPS) is the most common...
Tumor necrosis factor-alpha receptor (TNFR1)-associated periodic syndrome (TRAPS) is the most common...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
The anti-IL1 drug canakinumab has been administered in a patient with a high-penetrance T50M TNFRSF1...
Tumour necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant au...
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is an autosomal dominantly inher...
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), formerly known as familial Hibe...
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), formerly known as familial Hibe...
Management of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is puzzling, and t...
Objective. Tumor necrosis factor receptor (TNFR) -associated periodic syndrome (TRAPS) is an autosom...